Adalimumab was a first fully humanized monoclonal antibody approved by US Food and Drug Administration (FDA) in 2002. Clinical efficacy and safety of adalimumab has been assessed in various trials in rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis. It is one of the major sales success among biological and still one of the greatest blockbuster amongst monoclonal antibodies.
This report elaborates the market size, market characteristics, and market growth of the Adalimumab Biosimilar industry, and breaks down according to the type, application, and consumption area of Adalimumab Biosimilar. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Adalimumab Biosimilar in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Adalimumab Biosimilar market covered in Chapter 13:
Amgen
AET BioTech
Boehringer Ingelheim
Sandoz
Coherus Biosciences
Samsung Bioepsis
Zydus Cadila
Momenta Pharmaceuticals
LG Life Sciences/Mochida Pharmaceutical
Pfizer
Fujifilm Kyowa Kirin Biologics
Oncobiologics

In Chapter 6, on the basis of types, the Adalimumab Biosimilar market from 2015 to 2025 is primarily split into:
Exemptia
Adalirel
Cipleumab
Others

In Chapter 7, on the basis of applications, the Adalimumab Biosimilar market from 2015 to 2025 covers:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Table of Content

1 Adalimumab Biosimilar Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years

2 Adalimumab Biosimilar Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer

3 Adalimumab Biosimilar Market Forces
3.1 Global Adalimumab Biosimilar Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment

4 Adalimumab Biosimilar Market - By Geography
4.1 Global Adalimumab Biosimilar Market Value and Market Share by Regions
4.1.1 Global Adalimumab Biosimilar Value ($) by Region (2015-2020)
4.1.2 Global Adalimumab Biosimilar Value Market Share by Regions (2015-2020)
4.2 Global Adalimumab Biosimilar Market Production and Market Share by Major Countries
4.2.1 Global Adalimumab Biosimilar Production by Major Countries (2015-2020)
4.2.2 Global Adalimumab Biosimilar Production Market Share by Major Countries (2015-2020)
4.3 Global Adalimumab Biosimilar Market Consumption and Market Share by Regions
4.3.1 Global Adalimumab Biosimilar Consumption by Regions (2015-2020)
4.3.2 Global Adalimumab Biosimilar Consumption Market Share by Regions (2015-2020)

5 Adalimumab Biosimilar Market - By Trade Statistics
5.1 Global Adalimumab Biosimilar Export and Import
5.2 United States Adalimumab Biosimilar Export and Import (2015-2020)
5.3 Europe Adalimumab Biosimilar Export and Import (2015-2020)
5.4 China Adalimumab Biosimilar Export and Import (2015-2020)
5.5 Japan Adalimumab Biosimilar Export and Import (2015-2020)
5.6 India Adalimumab Biosimilar Export and Import (2015-2020)
5.7 ...

6 Adalimumab Biosimilar Market - By Type
6.1 Global Adalimumab Biosimilar Production and Market Share by Types (2015-2020)
6.1.1 Global Adalimumab Biosimilar Production by Types (2015-2020)
6.1.2 Global Adalimumab Biosimilar Production Market Share by Types (2015-2020)
6.2 Global Adalimumab Biosimilar Value and Market Share by Types (2015-2020)
6.2.1 Global Adalimumab Biosimilar Value by Types (2015-2020)
6.2.2 Global Adalimumab Biosimilar Value Market Share by Types (2015-2020)
6.3 Global Adalimumab Biosimilar Production, Price and Growth Rate of Exemptia (2015-2020)
6.4 Global Adalimumab Biosimilar Production, Price and Growth Rate of Adalirel (2015-2020)
6.5 Global Adalimumab Biosimilar Production, Price and Growth Rate of Cipleumab (2015-2020)
6.6 Global Adalimumab Biosimilar Production, Price and Growth Rate of Others (2015-2020)

7 Adalimumab Biosimilar Market - By Application
7.1 Global Adalimumab Biosimilar Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Adalimumab Biosimilar Consumption by Applications (2015-2020)
7.1.2 Global Adalimumab Biosimilar Consumption Market Share by Applications (2015-2020)
7.2 Global Adalimumab Biosimilar Consumption and Growth Rate of Hospital Pharmacy (2015-2020)
7.3 Global Adalimumab Biosimilar Consumption and Growth Rate of Retail Pharmacy (2015-2020)
7.4 Global Adalimumab Biosimilar Consumption and Growth Rate of Online Pharmacy (2015-2020)

8 North America Adalimumab Biosimilar Market
8.1 North America Adalimumab Biosimilar Market Size
8.2 United States Adalimumab Biosimilar Market Size
8.3 Canada Adalimumab Biosimilar Market Size
8.4 Mexico Adalimumab Biosimilar Market Size
8.5 The Influence of COVID-19 on North America Market

9 Europe Adalimumab Biosimilar Market Analysis
9.1 Europe Adalimumab Biosimilar Market Size
9.2 Germany Adalimumab Biosimilar Market Size
9.3 United Kingdom Adalimumab Biosimilar Market Size
9.4 France Adalimumab Biosimilar Market Size
9.5 Italy Adalimumab Biosimilar Market Size
9.6 Spain Adalimumab Biosimilar Market Size
9.7 The Influence of COVID-19 on Europe Market

10 Asia-Pacific Adalimumab Biosimilar Market Analysis
10.1 Asia-Pacific Adalimumab Biosimilar Market Size
10.2 China Adalimumab Biosimilar Market Size
10.3 Japan Adalimumab Biosimilar Market Size
10.4 South Korea Adalimumab Biosimilar Market Size
10.5 Southeast Asia Adalimumab Biosimilar Market Size
10.6 India Adalimumab Biosimilar Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market

11 Middle East and Africa Adalimumab Biosimilar Market Analysis
11.1 Middle East and Africa Adalimumab Biosimilar Market Size
11.2 Saudi Arabia Adalimumab Biosimilar Market Size
11.3 UAE Adalimumab Biosimilar Market Size
11.4 South Africa Adalimumab Biosimilar Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market

12 South America Adalimumab Biosimilar Market Analysis
12.1 South America Adalimumab Biosimilar Market Size
12.2 Brazil Adalimumab Biosimilar Market Size
12.3 The Influence of COVID-19 on South America Market

13 Company Profiles
13.1 Amgen
13.1.1 Amgen Basic Information
13.1.2 Amgen Product Profiles, Application and Specification
13.1.3 Amgen Adalimumab Biosimilar Market Performance (2015-2020)
13.2 AET BioTech
13.2.1 AET BioTech Basic Information
13.2.2 AET BioTech Product Profiles, Application and Specification
13.2.3 AET BioTech Adalimumab Biosimilar Market Performance (2015-2020)
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Basic Information
13.3.2 Boehringer Ingelheim Product Profiles, Application and Specification
13.3.3 Boehringer Ingelheim Adalimumab Biosimilar Market Performance (2015-2020)
13.4 Sandoz
13.4.1 Sandoz Basic Information
13.4.2 Sandoz Product Profiles, Application and Specification
13.4.3 Sandoz Adalimumab Biosimilar Market Performance (2015-2020)
13.5 Coherus Biosciences
13.5.1 Coherus Biosciences Basic Information
13.5.2 Coherus Biosciences Product Profiles, Application and Specification
13.5.3 Coherus Biosciences Adalimumab Biosimilar Market Performance (2015-2020)
13.6 Samsung Bioepsis
13.6.1 Samsung Bioepsis Basic Information
13.6.2 Samsung Bioepsis Product Profiles, Application and Specification
13.6.3 Samsung Bioepsis Adalimumab Biosimilar Market Performance (2015-2020)
13.7 Zydus Cadila
13.7.1 Zydus Cadila Basic Information
13.7.2 Zydus Cadila Product Profiles, Application and Specification
13.7.3 Zydus Cadila Adalimumab Biosimilar Market Performance (2015-2020)
13.8 Momenta Pharmaceuticals
13.8.1 Momenta Pharmaceuticals Basic Information
13.8.2 Momenta Pharmaceuticals Product Profiles, Application and Specification
13.8.3 Momenta Pharmaceuticals Adalimumab Biosimilar Market Performance (2015-2020)
13.9 LG Life Sciences/Mochida Pharmaceutical
13.9.1 LG Life Sciences/Mochida Pharmaceutical Basic Information
13.9.2 LG Life Sciences/Mochida Pharmaceutical Product Profiles, Application and Specification
13.9.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Market Performance (2015-2020)
13.10 Pfizer
13.10.1 Pfizer Basic Information
13.10.2 Pfizer Product Profiles, Application and Specification
13.10.3 Pfizer Adalimumab Biosimilar Market Performance (2015-2020)
13.11 Fujifilm Kyowa Kirin Biologics
13.11.1 Fujifilm Kyowa Kirin Biologics Basic Information
13.11.2 Fujifilm Kyowa Kirin Biologics Product Profiles, Application and Specification
13.11.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Market Performance (2015-2020)
13.12 Oncobiologics
13.12.1 Oncobiologics Basic Information
13.12.2 Oncobiologics Product Profiles, Application and Specification
13.12.3 Oncobiologics Adalimumab Biosimilar Market Performance (2015-2020)

14 Market Forecast - By Regions
14.1 North America Adalimumab Biosimilar Market Forecast (2020-2025)
14.2 Europe Adalimumab Biosimilar Market Forecast (2020-2025)
14.3 Asia-Pacific Adalimumab Biosimilar Market Forecast (2020-2025)
14.4 Middle East and Africa Adalimumab Biosimilar Market Forecast (2020-2025)
14.5 South America Adalimumab Biosimilar Market Forecast (2020-2025)

15 Market Forecast - By Type and Applications
15.1 Global Adalimumab Biosimilar Market Forecast by Types (2020-2025)
15.1.1 Global Adalimumab Biosimilar Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Adalimumab Biosimilar Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Adalimumab Biosimilar Market Forecast by Applications (2020-2025)

List of Tables and Figures

Figure Adalimumab Biosimilar Picture
Table Adalimumab Biosimilar Key Market Segments
Figure Study and Forecasting Years
Figure Global Adalimumab Biosimilar Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Adalimumab Biosimilar Value ($) and Growth Rate (2015-2020)
Table Global Adalimumab Biosimilar Value ($) by Countries (2015-2020)
Table Global Adalimumab Biosimilar Value Market Share by Regions (2015-2020)
Figure Global Adalimumab Biosimilar Value Market Share by Regions in 2019
Figure Global Adalimumab Biosimilar Production and Growth Rate (2015-2020)
Table Global Adalimumab Biosimilar Production by Major Countries (2015-2020)
Table Global Adalimumab Biosimilar Production Market Share by Major Countries (2015-2020)
Figure Global Adalimumab Biosimilar Production Market Share by Regions in 2019
Figure Global Adalimumab Biosimilar Consumption and Growth Rate (2015-2020)
Table Global Adalimumab Biosimilar Consumption by Regions (2015-2020)
Table Global Adalimumab Biosimilar Consumption Market Share by Regions (2015-2020)
Figure Global Adalimumab Biosimilar Consumption Market Share by Regions in 2019
Table Global Adalimumab Biosimilar Export Top 3 Country 2019
Table Global Adalimumab Biosimilar Import Top 3 Country 2019
Table United States Adalimumab Biosimilar Export and Import (2015-2020)
Table Europe Adalimumab Biosimilar Export and Import (2015-2020)
Table China Adalimumab Biosimilar Export and Import (2015-2020)
Table Japan Adalimumab Biosimilar Export and Import (2015-2020)
Table India Adalimumab Biosimilar Export and Import (2015-2020)
Table Global Adalimumab Biosimilar Production by Types (2015-2020)
Table Global Adalimumab Biosimilar Production Market Share by Types (2015-2020)
Figure Global Adalimumab Biosimilar Production Share by Type (2015-2020)
Table Global Adalimumab Biosimilar Value by Types (2015-2020)
Table Global Adalimumab Biosimilar Value Market Share by Types (2015-2020)
Figure Global Adalimumab Biosimilar Value Share by Type (2015-2020)
Figure Global Exemptia Production and Growth Rate (2015-2020)
Figure Global Exemptia Price (2015-2020)
Figure Global Adalirel Production and Growth Rate (2015-2020)
Figure Global Adalirel Price (2015-2020)
Figure Global Cipleumab Production and Growth Rate (2015-2020)
Figure Global Cipleumab Price (2015-2020)
Figure Global Others Production and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Adalimumab Biosimilar Consumption by Applications (2015-2020)
Table Global Adalimumab Biosimilar Consumption Market Share by Applications (2015-2020)
Figure Global Adalimumab Biosimilar Consumption Share by Application (2015-2020)
Figure Global Hospital Pharmacy Consumption and Growth Rate (2015-2020)
Figure Global Retail Pharmacy Consumption and Growth Rate (2015-2020)
Figure Global Online Pharmacy Consumption and Growth Rate (2015-2020)
Figure North America Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Table North America Adalimumab Biosimilar Consumption by Countries (2015-2020)
Table North America Adalimumab Biosimilar Consumption Market Share by Countries (2015-2020)
Figure North America Adalimumab Biosimilar Consumption Market Share by Countries (2015-2020)
Figure United States Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Canada Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Mexico Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Table Europe Adalimumab Biosimilar Consumption by Countries (2015-2020)
Table Europe Adalimumab Biosimilar Consumption Market Share by Countries (2015-2020)
Figure Europe Adalimumab Biosimilar Consumption Market Share by Countries (2015-2020)
Figure Germany Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure France Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Italy Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Spain Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Adalimumab Biosimilar Consumption by Countries (2015-2020)
Table Asia-Pacific Adalimumab Biosimilar Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Adalimumab Biosimilar Consumption Market Share by Countries (2015-2020)
Figure China Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Japan Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure South Korea Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure India Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Adalimumab Biosimilar Consumption by Countries (2015-2020)
Table Middle East and Africa Adalimumab Biosimilar Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Adalimumab Biosimilar Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure UAE Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure South Africa Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure South America Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Table South America Adalimumab Biosimilar Consumption by Countries (2015-2020)
Table South America Adalimumab Biosimilar Consumption Market Share by Countries (2015-2020)
Figure South America Adalimumab Biosimilar Consumption Market Share by Countries (2015-2020)
Figure Brazil Adalimumab Biosimilar Market Consumption and Growth Rate (2015-2020)
Table Amgen Company Profile
Table Amgen Production, Value, Price, Gross Margin 2015-2020
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2015-2020
Table AET BioTech Company Profile
Table AET BioTech Production, Value, Price, Gross Margin 2015-2020
Figure AET BioTech Production and Growth Rate
Figure AET BioTech Value ($) Market Share 2015-2020
Table Boehringer Ingelheim Company Profile
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2015-2020
Table Sandoz Company Profile
Table Sandoz Production, Value, Price, Gross Margin 2015-2020
Figure Sandoz Production and Growth Rate
Figure Sandoz Value ($) Market Share 2015-2020
Table Coherus Biosciences Company Profile
Table Coherus Biosciences Production, Value, Price, Gross Margin 2015-2020
Figure Coherus Biosciences Production and Growth Rate
Figure Coherus Biosciences Value ($) Market Share 2015-2020
Table Samsung Bioepsis Company Profile
Table Samsung Bioepsis Production, Value, Price, Gross Margin 2015-2020
Figure Samsung Bioepsis Production and Growth Rate
Figure Samsung Bioepsis Value ($) Market Share 2015-2020
Table Zydus Cadila Company Profile
Table Zydus Cadila Production, Value, Price, Gross Margin 2015-2020
Figure Zydus Cadila Production and Growth Rate
Figure Zydus Cadila Value ($) Market Share 2015-2020
Table Momenta Pharmaceuticals Company Profile
Table Momenta Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Momenta Pharmaceuticals Production and Growth Rate
Figure Momenta Pharmaceuticals Value ($) Market Share 2015-2020
Table LG Life Sciences/Mochida Pharmaceutical Company Profile
Table LG Life Sciences/Mochida Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
Figure LG Life Sciences/Mochida Pharmaceutical Production and Growth Rate
Figure LG Life Sciences/Mochida Pharmaceutical Value ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table Fujifilm Kyowa Kirin Biologics Company Profile
Table Fujifilm Kyowa Kirin Biologics Production, Value, Price, Gross Margin 2015-2020
Figure Fujifilm Kyowa Kirin Biologics Production and Growth Rate
Figure Fujifilm Kyowa Kirin Biologics Value ($) Market Share 2015-2020
Table Oncobiologics Company Profile
Table Oncobiologics Production, Value, Price, Gross Margin 2015-2020
Figure Oncobiologics Production and Growth Rate
Figure Oncobiologics Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Adalimumab Biosimilar Market Forecast Production by Types (2020-2025)
Table Global Adalimumab Biosimilar Market Forecast Production Share by Types (2020-2025)
Table Global Adalimumab Biosimilar Market Forecast Value ($) by Types (2020-2025)
Table Global Adalimumab Biosimilar Market Forecast Value Share by Types (2020-2025)
Table Global Adalimumab Biosimilar Market Forecast Consumption by Applications (2020-2025)
Table Global Adalimumab Biosimilar Market Forecast Consumption Share by Applications (2020-2025)